Acacia Research Corp
ACTG Nasdaq Patent Owners & Lessors Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$4.21
0.7%What Acacia Research Corp does
No business description yet.
- Legal name
- ACACIA RESEARCH CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 12, 2026
- Accession Β· CIK
- 0000934549-26-000010
0000934549
Revenue and margins
Acacia Research Corp had $285M of revenue in fiscal 2025, up 133.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Acacia Research Corp returned $0.0M to shareholders in fiscal 2025. The diluted share count fell 2.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Acacia Research Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $707M | $386M | $440M | $274M | $307M |
| Debt incl. finance leases | β | β | β | $2.4M | $91.9M |
| Net debt / EBITDA | β | β | β | β419.0x | β4.3x |
| Debt / equity | β | β | β | 0.0x | 0.2x |
| Interest coverage | 1.8x | β6.2x | 10.1x | β5.1x | 0.7x |
| Current ratio | 3.6x | 4.9x | 20.1x | 8.5x | 9.2x |
| Quick ratio | 3.6x | 4.7x | 19.7x | 7.9x | 8.6x |
| Total assets | $799M | $483M | $634M | $756M | $771M |
| Total liabilities | $354M | $194M | $43.9M | $204M | $187M |
| Shareholders' equity | $419M | $258M | $568M | $515M | $543M |
| Net debt (β = net cash) | β | β | β | β$271M | β$215M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | 4 / 7 | 3 / 8 | 4 / 8 | 3 / 8 | 4 / 8 | 5 / 8 | 2 / 8 | 8 / 9 |
| Accruals ratio | β29.8% | 3.0% | β47.3% | β6.7% | 35.3% | 20.7% | β13.7% | 16.0% | β12.4% | β7.0% |
| Altman Z'' | 8.70 | 22.37 | 4.18 | 2.74 | 3.28 | 4.98 | 3.40 | 18.02 | 4.38 | 5.45 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | $65.4M | $132M | $11.2M | $29.8M | $12.0M | $59.2M | $125M | $122M | $285M |
| Gross profit | β | β | $22.2M | β$7.0M | $5.0M | $51.9M | $21.8M | $72.3M | $29.7M | $84.5M |
| Research and development | β | β | β | β | $0.0M | $0.2M | $0.6M | $0.7M | β | β |
| Operating income | β$37.4M | β$27.3M | β$24.7M | β$23.4M | β$19.5M | $14.5M | β$40.1M | $20.9M | β$32.9M | $6.4M |
| Interest expense | β | β | β | $0.0M | $10.1M | $7.9M | $6.4M | $2.1M | $6.5M | $9.0M |
| Pretax income | β$36.6M | $24.6M | β$104M | β$19.0M | $108M | $175M | β$127M | $67.4M | β$38.1M | $31.3M |
| Income tax | $18.2M | $3.0M | $1.2M | β$1.8M | β$1.2M | $24.3M | β$16.2M | β$1.5M | β$3.4M | $6.8M |
| Net income | β$54.1M | $22.2M | β$105M | β$17.1M | $109M | $149M | β$125M | $67.1M | β$36.1M | $21.7M |
| Net income to common | β$54.1M | $22.1M | β$105M | β$17.4M | $86.8M | $119M | β$133M | $55.1M | β$36.1M | $21.7M |
| Diluted EPS | β$1.08 | $0.44 | β$2.10 | β$0.40 | $1.48 | $1.91 | β$3.13 | $0.58 | β$0.36 | $0.22 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B | 0.10B | 0.04B | 0.09B | 0.10B | 0.10B |
| Cash flow | ||||||||||
| Cash from operations | $34.1M | $13.0M | $20.9M | β$2.3M | β$19.6M | $13.3M | β$37.3M | β$22.5M | $50.1M | $75.2M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | $0.2M | $0.2M | $0.1M | $0.7M | $0.2M | $149M | β |
| Free cash flow | $34.1M | $13.0M | $20.8M | β$2.5M | β$19.8M | $13.2M | β$38.1M | β$22.7M | β$98.5M | β |
| Depreciation and amortization | $34.4M | $22.2M | $27.1M | $3.2M | $4.8M | $10.7M | $13.5M | $14.7M | $33.6M | $43.3M |
| Stock-based compensation | $9.1M | $8.9M | β$0.3M | $1.1M | $1.7M | $2.1M | $3.8M | $3.3M | $4.8M | $5.7M |
| Acquisitions | β | β | β | β | $0.0M | $33.3M | $0.0M | $9.4M | $87.7M | β$1.2M |
| Share buybacks | $0.1M | $0.0M | $4.6M | $0.0M | $4.0M | $4.0M | $51.0M | $0.0M | $20.3M | $0.0M |
| Dividends paid | $0.0M | $0.0M | β | $0.0M | $1.4M | $1.5M | $2.8M | $1.4M | $0.0M | β |
| Dividends and buybacks | $0.1M | $0.0M | $4.6M | $0.0M | $5.4M | $5.5M | $53.8M | $1.4M | $20.3M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $158M | $137M | $166M | $169M | $166M | $707M | $386M | $440M | $274M | $307M |
| Total debt | β | β | β | β | β | β | β | β | $2.4M | $91.9M |
| Current assets | $188M | $140M | $201M | $173M | $458M | $731M | $428M | $555M | $420M | $450M |
| Current liabilities | $28.2M | $9.6M | $31.0M | $11.7M | $125M | $200M | $87.2M | $27.6M | $49.6M | $49.0M |
| Inventory | β | β | β | β | $0.0M | $8.9M | $14.2M | $10.9M | $27.5M | $26.6M |
| Property and equipment, net | $0.1M | β | β | β | $0.3M | $4.2M | $3.5M | $2.4M | $23.9M | $21.3M |
| Goodwill | β | β | β | β | $0.0M | $7.5M | $7.5M | $9.0M | $29.3M | $25.8M |
| Intangible assets | β | β | $6.6M | $7.8M | $16.9M | $48.8M | $36.7M | $33.6M | $55.4M | $48.1M |
| Total assets | $296M | $309M | $224M | $218M | $511M | $799M | $483M | $634M | $756M | $771M |
| Total liabilities | $28.6M | $13.1M | $32.7M | $35.1M | $212M | $354M | $194M | $43.9M | $204M | $187M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $266M | $294M | $189M | $173M | $277M | $419M | $258M | $568M | $515M | $543M |
| Margins | ||||||||||
| Gross margin | β | β | 16.9% | β62.6% | 16.6% | 432.8% | 36.9% | 57.8% | 24.2% | 29.6% |
| Operating margin | β | β41.7% | β18.8% | β208.2% | β65.5% | 121.2% | β67.7% | 16.7% | β26.9% | 2.2% |
| EBITDA margin | β | β7.7% | 1.9% | β179.5% | β49.4% | 210.2% | β44.9% | 28.5% | 0.5% | 17.4% |
| Net margin | β | 33.9% | β79.9% | β152.2% | 366.8% | 1,242.9% | β211.2% | 53.6% | β29.5% | 7.6% |
| FCF margin | β | 19.8% | 15.8% | β22.2% | β66.5% | 110.3% | β64.3% | β18.1% | β80.6% | β |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | β10.7% | 1.5% |
| Return on capital employed | β14.0% | β9.1% | β12.8% | β11.3% | β5.1% | 2.4% | β10.1% | 3.5% | β4.7% | 0.9% |
| Return on equity | β20.4% | 7.9% | β43.4% | β9.4% | 48.5% | 42.8% | β36.9% | 16.2% | β6.7% | 4.1% |
| Return on assets | β18.3% | 7.3% | β39.4% | β7.7% | 29.9% | 22.8% | β19.5% | 12.0% | β5.2% | 2.8% |
| Return on tangible equity | β20.4% | 7.5% | β57.5% | β10.5% | 33.4% | 32.7% | β62.1% | 10.5% | β8.4% | 4.6% |
| Growth | ||||||||||
| Revenue growth | β | β | 101.1% | β91.4% | 164.8% | β59.7% | 393.4% | 111.2% | β2.2% | 133.2% |
| Net income growth | β | β | β573.5% | β | β | 36.6% | β183.8% | β | β153.8% | β |
| EPS growth | β | β | β577.3% | β | β | 29.1% | β263.9% | β | β162.1% | β |
| FCF growth | β | β61.9% | 60.8% | β112.0% | β | β | β387.6% | β | β | β |
| Share count change | β | 1.2% | β1.4% | 1.9% | 12.8% | 71.4% | β56.9% | 117.6% | 7.4% | β2.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | β419.0x | β4.3x |
| Debt / equity | β | β | β | β | β | β | β | β | 0.0x | 0.2x |
| Interest coverage | β | β | β | β | β1.9x | 1.8x | β6.2x | 10.1x | β5.1x | 0.7x |
| Current ratio | 6.7x | 14.6x | 6.5x | 14.8x | 3.7x | 3.6x | 4.9x | 20.1x | 8.5x | 9.2x |
| Quick ratio | 6.7x | 14.6x | 6.5x | 14.8x | 3.7x | 3.6x | 4.7x | 19.7x | 7.9x | 8.6x |
| Capital allocation | ||||||||||
| Capex / revenue | β | 0.0% | 0.0% | 1.6% | 0.7% | 0.8% | 1.2% | 0.2% | 121.5% | β |
| Stock comp / revenue | β | 13.6% | β0.2% | 9.6% | 5.6% | 17.1% | 6.5% | 2.6% | 3.9% | 2.0% |
| Payouts / FCF | 0.2% | 0.0% | 22.2% | β | β | 41.3% | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 4.0 | 3.0 | 4.0 | 3.0 | 4.0 | 5.0 | 2.0 | 8.0 |
| Altman Z'' | 8.7 | 22.4 | 4.2 | 2.7 | 3.3 | 5.0 | 3.4 | 18.0 | 4.4 | 5.4 |
| Accruals ratio | β29.8% | 3.0% | β47.3% | β6.7% | 35.3% | 20.7% | β13.7% | 16.0% | β12.4% | β7.0% |
Source: SEC EDGAR XBRL filings (CIK 0000934549). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.